BioInvent International AB (BINV) — Working Capital to Net Assets Ratio

Latest as of June 2025: 95.5%

BioInvent International AB (BINV) has a Working Capital to Net Assets ratio of 95.5% as of June 2025. Working capital of Skr774.60 Million (current assets of Skr876.71 Million minus current liabilities of Skr102.11 Million) is measured against net assets of Skr810.74 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See BioInvent International AB balance sheet independence to measure how much of total assets are equity-financed.

WC/NA Ratio

95.5%
Working Capital / Net Assets

Working Capital

Skr774.60 Million
SEK

Current Assets

Skr876.71 Million
SEK

Current Liabilities

Skr102.11 Million
SEK

BioInvent International AB Working Capital to Net Assets (2002–2024)

This chart shows how BioInvent International AB's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2002 to 2024. As of June 2025, the ratio stands at 95.5%, reflecting working capital of Skr774.60 Million against net assets of Skr810.74 Million SEK. Check BioInvent International AB tangible equity quality to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for BioInvent International AB (2002–2024)

The table below presents the year-by-year Working Capital to Net Assets ratio for BioInvent International AB from 2002 to 2024, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see BioInvent International AB stock valuation.

Year WC/NA Ratio Working Capital (SEK) Net Assets Current Assets Current Liabilities Change (pp)
2024 95.7% Skr848.01 Million Skr885.82 Million Skr943.21 Million Skr95.21 Million ▲ +15.0 pp
2023 80.7% Skr1.06 Billion Skr1.31 Billion Skr1.13 Billion Skr75.92 Million ▲ +18.7 pp
2022 62.1% Skr996.74 Million Skr1.61 Billion Skr1.08 Billion Skr87.32 Million ▼ -15.3 pp
2021 77.3% Skr1.06 Billion Skr1.37 Billion Skr1.12 Billion Skr58.79 Million ▼ -19.4 pp
2020 96.8% Skr719.53 Million Skr743.50 Million Skr773.04 Million Skr53.51 Million ▲ +10.7 pp
2019 86.1% Skr145.90 Million Skr169.44 Million Skr193.11 Million Skr47.20 Million ▲ +6.7 pp
2018 79.4% Skr69.59 Million Skr87.62 Million Skr102.37 Million Skr32.78 Million ▼ -5.8 pp
2017 85.2% Skr110.98 Million Skr130.22 Million Skr150.80 Million Skr39.82 Million ▼ -12.3 pp
2016 97.5% Skr224.79 Million Skr230.44 Million Skr270.65 Million Skr45.86 Million ▲ +2.0 pp
2015 95.5% Skr28.13 Million Skr29.45 Million Skr53.12 Million Skr24.99 Million ▲ +8.5 pp
2014 87.0% Skr45.63 Million Skr52.43 Million Skr67.31 Million Skr21.68 Million ▼ -5.0 pp
2013 92.0% Skr45.08 Million Skr49.01 Million Skr77.51 Million Skr32.43 Million ▲ +6.2 pp
2012 85.8% Skr40.85 Million Skr47.62 Million Skr109.77 Million Skr68.92 Million ▼ -4.9 pp
2011 90.7% Skr125.09 Million Skr137.95 Million Skr192.90 Million Skr67.81 Million ▲ +9.9 pp
2010 80.8% Skr59.94 Million Skr74.19 Million Skr123.78 Million Skr63.84 Million ▲ +14.9 pp
2009 65.9% Skr36.64 Million Skr55.63 Million Skr107.25 Million Skr70.61 Million ▲ +1.7 pp
2008 64.1% Skr148.33 Million Skr231.30 Million Skr212.46 Million Skr64.13 Million ▼ -23.4 pp
2007 87.5% Skr187.40 Million Skr214.12 Million Skr244.29 Million Skr56.88 Million ▲ +19.4 pp
2006 68.1% Skr75.03 Million Skr110.15 Million Skr113.21 Million Skr38.18 Million ▼ -12.9 pp
2005 81.0% Skr177.43 Million Skr219.00 Million Skr224.77 Million Skr47.34 Million ▼ -0.9 pp
2004 81.9% Skr174.17 Million Skr212.68 Million Skr199.90 Million Skr25.73 Million ▼ -0.4 pp
2003 82.3% Skr251.05 Million Skr304.96 Million Skr289.28 Million Skr38.23 Million ▼ -1.6 pp
2002 83.9% Skr330.71 Million Skr394.25 Million Skr382.87 Million Skr52.16 Million —
pp = percentage points